Buprenorphine and Metabolites, Quant, serum/plasma




Test Mnemonic

SBUP

CPT Codes

  • 80348 - QTY (1)
  • G0480 - QTY (1)

Includes

  • Buprenorphine
  • Norbuprenorphine

Performing Laboratory

ARUP

FDA Category

Laboratory Developed Test


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 mLSerumNo additive (Red) RefrigeratedDo not use serum separator tubes; Remove serum from cells ASAP or within 2 hours of collection.

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 mLPlasmaPotassium oxalate/sodium fluoride (Gray) RefrigeratedDo not use plasma separator tubes; Remove plasma from cells ASAP or within 2 hours of collection.
2 mLPlasmaSodium heparin (Green) RefrigeratedDo not use plasma separator tubes; Remove plasma from cells ASAP or within 2 hours of collection.
2 mLPlasmaEDTA (Lavender) RefrigeratedDo not use plasma separator tubes; Remove plasma from cells ASAP or within 2 hours of collection.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mL     

Stability

Environmental Condition Description
AmbientAfter separation from cells: 1 week
RefrigeratedAfter separation from cells: 2 weeks
FrozenAfter separation from cells: 3 years (Avoid repeated freeze/thaw cycles)

Days Performed

Tue, Fri

Turnaround Time

2 - 8 days

Methodology

Name Description
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 

Reference Range

Buprenorphine Serum/Plasma
Sex Age From Age To Type Range Range Unit
   Years99 YearsNormal1ng/mL
Norbuprenorphine, Serum/Plasma
Sex Age From Age To Type Range Range Unit
   Years99 YearsNormal1ng/mL

Special Info

This test is a reflex from Drug Screen 9 Panel, Serum or Plasma (DRGSC9). This test is New York DOH approved.

Clinical Info

Positive Cutoff: 1 ng/mL. The presence of metabolites(s) without parent drug may indicate use of parent drug during the prior week. The absence of expected drug(s) and/or metabolite(s) may indicate noncompliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive.

Clinical Limitation

For medical purposes only; not valid for forensic use.